Abstract
Blinatumomab in Children with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R-ALL): Final Results of 110 Patients Treated in an Expanded Access Study (RIALTO)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have